The UAMS Cancer Institute is home to Arkansas’ only adult blood and marrow transplant program.

The program offers two types of transplants:

Allogeneic transplants involve the transplantation of stem cells obtained from a donor and are used to treat patients with lymphomas and leukemias.Fact

Autologous transplants involve collection of stem cells from a patient’s own bone marrow or blood to be infused into the patient. This type of transplant is used to treat patients with multiple myeloma and related conditions.

The autologous transplant program has been continually accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) since 2009. The allogeneic transplant program became FACT accredited in  2019.

Patients are seen by a multidisciplinary health care team specially trained in diagnosis and treatment of multiple conditions, including:

  • Blood cancers
  • Nonmalignant acquired bone marrow disorders
  • Genetic diseases
  • Bleeding disorders
  • Sickle cell anemia
  • Solid tumors

Meet the Team

Allogeneic Stem Cell Transplantation



Autologous Stem Cell Transplantation




The  UAMS Cancer Institute continues to uncover scientific advances that translate into therapy:

  • Only Adult Allogeneic Stem Cell Transplant team in Arkansas
  • Only Adult Sickle Cell Clinic in Arkansas
  • First bone marrow transplant in Arkansas
  • First to initiate use of tandem stem cell transplants
  • First outpatient stem cell transplant (autologous)
  • First stem cell transplant for patients over the age of 70
  • Initiation of idiotype and dendritic cell vaccines
  • Creation of stem cell purification process

Be The Match

Interested in possibly becoming a stem cell donor? Visit